Company intelligence / Profile preview

BioLife Sciences

Bothell, Washington, United States

Ownership: Private
Employees: ~400
Development stage: Other

Overview

BioLife Solutions’ products are cited in over 700 scientific articles, supporting clinical programs and at least 15 commercial gene/cell therapies. Their products underpin workflow reliability and scalability for cell/gene therapy manufacture, storage, distribution, and administration

Modalities: BiologicCell therapyGene therapy
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on BioLife Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioLife Sciences.

Explore the full profile